Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 FDA Issues Safety Alert on Reumofan Plus and Reumofan Plus Premium - Nutraceuticals World
Market Updates

FDA Issues Safety Alert on Reumofan Plus and Reumofan Plus Premium

The U.S. Food and Drug Administration (FDA) has issued a new warning to about the potential health risks of two products marketed as natural dietary supplements for treating arthritis, muscle pain, osteoporosis, bone cancer, and other conditions. The products, Reumofan Plus and Reumofan Plus Premium, contain several potentially harmful active pharmaceutical ingredients that are not listed on the product labels. FDA has received dozens of additional adverse event reports, including death and stroke, associated with the use of Reumofan Plus since the agency issued its first warning about the product on June 1, 2012. Other reports include liver injury, severe bleeding, sudden worsening of glucose control, weight gain, swelling, leg cramps and withdrawal syndrome, and adrenal suppression. Ongoing FDA laboratory analyses of Reumofan Plus found that it contains the prescription drug ingredients dexamethasone , diclofenac sodium, and methocarbamol. The products are manufactured in Mexico by Riger Naturals and sold in the U.S. in some retail outlets, at flea markets, and on various popular Internet sites.

Add us as a preferred source on Google

Get the latest Nutraceuticals World news, insights and analysis in your Google Search and AI experiences.

Keep Up With Our Content. Subscribe To Nutraceuticals World Newsletters